The 4 most recent market catalysts affecting $SXTC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Aug 5, 2026
Corporate Catalyst
Bearish
Impact 85
China SXT Pharmaceuticals shares are trading lower after the company announced a 1-for-80 reverse stock split.
A 1-for-80 reverse stock split is an extreme measure, indicating severe share price depreciation and likely a company struggling to meet minimum bid price requirements for exchange…
Aug 5, 2026
Corporate Catalyst
Neutral
Impact 75
China SXT Pharmaceuticals Announces 1-For-80 Reverse Stock Split, Effective Aug. 10
China SXT Pharmaceuticals is implementing a 1-for-80 reverse stock split, a corporate action where the number of outstanding shares is reduced, and the price per share is proportio…
Jul 23, 2026
Corporate Catalyst
Bearish
Impact 75
China SXT Pharmaceuticals shares are trading lower after the company announced a $9 million registered direct offering.
The announcement of a registered direct offering for China SXT Pharmaceuticals (SXTC) is a significant corporate catalyst. These offerings increase the number of outstanding shares…
Jul 23, 2026
Corporate Catalyst
Bullish
Impact 75
China SXT Pharmaceuticals Commences ~$9M Offering Of 4.5M Class Ordinary Shares At $3.20/Share
China SXT Pharmaceuticals (SXTC) announced a registered direct offering to raise approximately $9 million. The company will sell 4.5 million units, each comprising a Class A ordina…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.